VCEL (VCEL) Stock Price & Analysis
VCEL (VCEL) fell 2.14% to USD 39.33 as of September 8, 2026 at 17:34 UTC, according to Nexqual real-time market data.
VCEL last closed at USD 39.33; the session ranged USD 38.74–39.72 on volume of 184,690 shares. Market capitalization is —, with a 52-week range of USD 28.95–49.32 (NGM). Source: Nexqual, September 8, 2026 at 17:34 UTC.
Key Statistics (as of September 8, 2026 at 17:34 UTC)
| Price | USD 39.33 |
|---|---|
| Change | ▼ 2.14% (down) |
| Previous Close | USD 39.33 |
| Open | USD 39.33 |
| Day Range | USD 38.74 – 39.72 |
| 52-Week Range | USD 28.95 – 49.32 |
| Volume | 184,690 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (VCEL)
Nexqual's technical model rates VCEL "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 17:34 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 32.18 (neutral) |
| vs SMA50 | Below (USD 44.56) |
| MACD | -1.23 (negative) |
From VCEL's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| XNCR | Xencor, Inc. | USD 25.44 | ▼ 4.43% |
| VCYT | Veracyte, Inc. | USD 42.93 | ▼ 3.9% |
| PTCT | PTC Therapeutics, Inc. | USD 70.02 | ▼ 1.93% |
| SNDX | Syndax Pharmaceuticals, Inc. | USD 20.25 | ▼ 2.08% |
| RGNX | REGENXBIO Inc. | USD 8.74 | ▼ 5% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 17:34 UTC. This page is informational and not investment advice.